HPGC RENMINTONGTAI PHARMACEUTICAL CORPORATION financial statements, including revenue, expenses, profit, and loss

The total revenue of 600829 for the last quarter is 2.59 B CNY, and it's 1.32% higher compared to the previous quarter. The net income of Q1 24 is 78.33 M CNY.